RxDoctor Payments Data

Brittany Fuller, PA

Medical · Quinlan, TXNPI 1851317978

Payments from drug & device makers

$286in general payments, 2019–2025

Across 14 payments — averaging $20.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$119
  • Corcept Therapeutics$41
  • Bayer$26
  • Phathom Pharmaceuticals, Inc.$21
  • GSK$19
  • AbbVie$17
  • plus $43 from 3 others

What the payments were for

  • Food & beverage$26994%
  • Education$176%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$286 in reported general payments places this provider in the 35th percentile of 1,490 medical providers in Texas.

See all medical providers in Texas

Medicare billing

Part B allowed, 2024
$2,925
Medicare patients
42
Services billed
138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban48$62,802
JanuviaSitagliptin Phosphate58$57,413
Trelegy ElliptaFluticasone/Umeclidin/Vilanter69$54,807
OzempicSemaglutide32$34,844
RybelsusSemaglutide15$32,576
MounjaroTirzepatide19$27,514
XareltoRivaroxaban15$20,277
Breo ElliptaFluticasone/Vilanterol34$16,552
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$16,184
Spiriva RespimatTiotropium Bromide13$13,034
FarxigaDapagliflozin Propanediol18$12,961
SymbicortBudesonide/Formoterol Fumarate43$9,835
Lantus SolostarInsulin Glargine,hum.Rec.Anlog44$9,471
Gabapentin278$5,801
Omeprazole236$5,231

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$19$71,359103 claims
MerckJanuvia$15$57,41358 claims
Lilly USA, LLCMounjaro$16$27,51419 claims
AstraZenecaFarxiga, Symbicort$13$22,79661 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 1,490 medical providers in Texas.

Other medical in Quinlan

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →